Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B

References

• JemalAMurrayTWardESamuelsAErratum: Cancer statistics, 2005 (Ca – A Cancer Journal for Clinicians (January/February 2005) 55 (10–30))CA Cancer J Clin2005554259
   Google Scholar
• SchoutenLJGoldbohmRAvan den BrandtPAAnthropometryPVDBAnthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort StudyJ Natl Cancer Inst200496211635163815523093
   PubMedGoogle Scholar
• HumberCTierneyJSymondsPChemotherapy for advanced, recurrent or metastatic endometrial carcinomaCochrane Database Syst Rev200553CD003915
   Google Scholar
• AlvarezTMillerEDuskaLOlivaEMolecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?Am J Surg Pathol201236575322498825
   PubMed Web of Science ®Google Scholar
• LuSSinghKMangraySClaudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtypeMod Pathol201326448549523222490
   PubMed Web of Science ®Google Scholar
• GünzelDYuASAslYClaudins and the modulation of tight junction permeabilityPhysiol Rev201393252556923589827
   PubMed Web of Science ®Google Scholar
• OshimaTMiwaHGastrointestinal mucosal barrier function and diseasesJ Gastroenterol201651876877827048502
   PubMed Web of Science ®Google Scholar
• MorohashiSKusumiTSatoFDecreased expression of claudin-1 correlates with recurrence status in breast cancerInt J Mol Med200720213917611630
   PubMed Web of Science ®Google Scholar
• MaedaTMurataMChibaHClaudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancerProstate201272435136021656836
   PubMed Web of Science ®Google Scholar
• SeoHWRengarajDChoiJWClaudin 10 is a glandular epithelial marker in the chicken model as human epithelial ovarian cancerInt J Gynecol Cancer2010209146521370593
   PubMed Web of Science ®Google Scholar
• Rendon-HuertaEPTorres-MartínezACMontañoLCLDN6 (claudin 6)Atlas Genet Cytogenet Oncol Haematol2013176396399
   Google Scholar
• RenYWuQLiuYXuXQuanCGene silencing of claudin-6 enhances cell proliferation and migration accompanied with increased MMP-2 activity via p38 MAPK signaling pathway in human breast epithelium cell line HBL-100Mol Med Rep2013851505151024026616
   PubMed Web of Science ®Google Scholar
• XuXJinHLiuYThe expression patterns and correlations of claudin-6, methy-CpG binding protein 2, DNA methyltransferase 1, histone deacetylase 1, acetyl-histone H3 and acetyl-histone H4 and their clinicopathological significance in breast invasive ductal carcinomasDiagn Pathol2012713322455563
   PubMed Web of Science ®Google Scholar
• WuQLiuXLiuYFInhibition of p38 activity reverses claudin-6 induced cell apoptosis, invasion, and migrationChin Med J (Engl)2013126183539354424034105
   PubMed Web of Science ®Google Scholar
• Zavala-ZendejasVETorres-MartinezACSalas-MoralesBFortoulTIMontañoLFRendon-HuertaEPClaudin-6, 7, or 9 overexpression in the human gastric adenocarcinoma cell line AGS increases its invasiveness, migration, and proliferation rateCancer Invest201129111120874001
   PubMed Web of Science ®Google Scholar
• SullivanLMYankovichTLePClaudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumorsAm J Surg Pathol2012361738021989342
   PubMed Web of Science ®Google Scholar
• RitchieMEPhipsonBWuDLimma powers differential expression analyses for RNA-sequencing and microarray studiesNucleic Acids Res2015437e4725605792
   PubMed Web of Science ®Google Scholar
• ZhangXQiHWangSCellular responses of aniline oligomers: a preliminary studyToxicol Res201213201205
   Web of Science ®Google Scholar
• JordanNVJohnsonGLAbellANTracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancerCell Cycle201110172865287321862874
   PubMed Web of Science ®Google Scholar
• MartinTAJiangWGLoss of tight junction barrier function and its role in cancer metastasisBiochim Biophys Acta20091788487289119059202
   PubMed Web of Science ®Google Scholar
• Zavala-ZendejasVETorres-MartinezACSalas-MoralesBFortoulTIMontañoLFRendon-HuertaEPClaudin-6, 7, or 9 overexpression in the human gastric adenocarcinoma cell line AGS increases its invasiveness, migration, and proliferation rateCancer Invest201129111120874001
   PubMed Web of Science ®Google Scholar
• TsunodaSSmithEde YoungNJMethylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinomaOncol Rep2009214106719288010
   PubMed Web of Science ®Google Scholar
• MickePMattssonJSEdlundKAberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancerInt J Cancer201413592206221424710653
   PubMed Web of Science ®Google Scholar
• LiuYJinXLiYDNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4AcJ Exp Clin Cancer Res201635112027461117
   PubMed Web of Science ®Google Scholar
• BirksDKKleinschmidt-DemastersBKDonsonAMClaudin 6 is a positive marker for atypical teratoid/rhabdoid tumorsBrain Pathol201020114015019220299
   PubMed Web of Science ®Google Scholar
• LuYWangLLiHSMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer CellsInt J Mol Sci20171891863
   Web of Science ®Google Scholar
• TsukitaSYamazakiYKatsunoTTamuraATsukitaSTight junction-based epithelial microenvironment and cell proliferationOncogene200827556930693819029935
   PubMed Web of Science ®Google Scholar
• HouédéNPourquierPTargeting the genetic alterations of the PI3K-AKT-mTOR pathway: its potential use in the treatment of bladder cancersPharmacol Ther20151453311824929024
   PubMed Web of Science ®Google Scholar
• ZhuLDerijardBChakrabandhuKWangBSChenHZHueberAOSynergism of PI3K/Akt inhibition and Fas activation on colon cancer cell deathCancer Lett2014354235536425199763
   PubMed Web of Science ®Google Scholar
• DenoyelleCLambertBMeryet-FiguièreMmiR-491-5p-induced apoptosis in ovarian carcinoma depends on the direct inhibition of both BCL-XL and EGFR leading to BIM activationCell Death Dis2014510e144525299770
   PubMed Web of Science ®Google Scholar
• HyYKimSOJinCβ-lapachone-Induced Apoptosis of Human Gastric Carcinoma AGS Cells Is Caspase-Dependent and Regulated by the PI3K/Akt PathwayBiomol Ther2014223184192
   Web of Science ®Google Scholar
• ShangH-SChangJ-BLinJ-HDeguelin Inhibits the Migration and Invasion of U-2 OS Human Osteosarcoma Cells via the Inhibition of Matrix Metalloproteinase-2/-9 in VitroMolecules20141910165881660825322282
   PubMed Web of Science ®Google Scholar
• GilleHKowalskiJLiBAnalysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutantsJ Biol Chem20012765322211058584
   PubMed Web of Science ®Google Scholar
• TrisciuoglioDIervolinoAZupiGdel BufaloDdelBDInvolvement of PI3K and MAPK signaling in bcl-2-induced vascular endothelial growth factor expression in melanoma cellsMol Biol Cell20051694153416215987743
   PubMed Web of Science ®Google Scholar
• ErdemOErdemMDursunAAkyolGErdemAAngiogenesis, p53, and bcl-2 expression as prognostic indicators in endometrial cancer: comparison with traditional clinicopathologic variablesInt J Gynecol Pathol200322325426012819392
   PubMed Web of Science ®Google Scholar
• SlomovitzBMColemanRLThe PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancerClin Cancer Res201218215856586423082003
   PubMed Web of Science ®Google Scholar
• ZhangSWangMLiQZhuPMiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTORCancer Biomarkers201721117918629081412
   PubMed Web of Science ®Google Scholar